9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Dravet syndrome: Treatment options and management of prolonged seizures

      1 , 2 , 3 , 4 , 5 , 6 , 7 , 8
      Epilepsia
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references61

          • Record: found
          • Abstract: found
          • Article: not found

          A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus.

          The Commission on Classification and Terminology and the Commission on Epidemiology of the International League Against Epilepsy (ILAE) have charged a Task Force to revise concepts, definition, and classification of status epilepticus (SE). The proposed new definition of SE is as follows: Status epilepticus is a condition resulting either from the failure of the mechanisms responsible for seizure termination or from the initiation of mechanisms, which lead to abnormally, prolonged seizures (after time point t1 ). It is a condition, which can have long-term consequences (after time point t2 ), including neuronal death, neuronal injury, and alteration of neuronal networks, depending on the type and duration of seizures. This definition is conceptual, with two operational dimensions: the first is the length of the seizure and the time point (t1 ) beyond which the seizure should be regarded as "continuous seizure activity." The second time point (t2 ) is the time of ongoing seizure activity after which there is a risk of long-term consequences. In the case of convulsive (tonic-clonic) SE, both time points (t1 at 5 min and t2 at 30 min) are based on animal experiments and clinical research. This evidence is incomplete, and there is furthermore considerable variation, so these time points should be considered as the best estimates currently available. Data are not yet available for other forms of SE, but as knowledge and understanding increase, time points can be defined for specific forms of SE based on scientific evidence and incorporated into the definition, without changing the underlying concepts. A new diagnostic classification system of SE is proposed, which will provide a framework for clinical diagnosis, investigation, and therapeutic approaches for each patient. There are four axes: (1) semiology; (2) etiology; (3) electroencephalography (EEG) correlates; and (4) age. Axis 1 (semiology) lists different forms of SE divided into those with prominent motor systems, those without prominent motor systems, and currently indeterminate conditions (such as acute confusional states with epileptiform EEG patterns). Axis 2 (etiology) is divided into subcategories of known and unknown causes. Axis 3 (EEG correlates) adopts the latest recommendations by consensus panels to use the following descriptors for the EEG: name of pattern, morphology, location, time-related features, modulation, and effect of intervention. Finally, axis 4 divides age groups into neonatal, infancy, childhood, adolescent and adulthood, and elderly.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

            New England Journal of Medicine, 376(21), 2011-2020
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

              Cannabidiol has been used for treatment-resistant seizures in patients with severe early-onset epilepsy. We investigated the efficacy and safety of cannabidiol added to a regimen of conventional antiepileptic medication to treat drop seizures in patients with the Lennox-Gastaut syndrome, a severe developmental epileptic encephalopathy.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                Epilepsia
                Epilepsia
                Wiley
                0013-9580
                1528-1167
                December 2019
                December 2019
                : 60
                : S3
                Affiliations
                [1 ]University College London National Institute for Health Research Biomedical Research Centre Great Ormond Street Institute of Child Health London UK
                [2 ]Great Ormond Street Hospital for Children London UK
                [3 ]Department of Neurology J. P. Garrahan Hospital, Capital Federal Buenos Aires Argentina
                [4 ]Référence centre for rare épilepsies, department of pediatric neurology necker enfants malades hospital, aphp, Paris Descartes university Paris France
                [5 ]Imagine institute insermU1163Paris France
                [6 ]Pediatric Neurology Unit Bambino Gesù Children's Hospital Rome Italy
                [7 ]Pediatric Neurology Unit A. Meyer Children's HospitalUniversity of Florence Florence Italy
                [8 ]Department of Pediatric Neurology UZ Leuven Leuven Belgium
                Article
                10.1111/epi.16334
                31904119
                1a99ae88-e98e-457c-bb11-0c30e69393a7
                © 2019

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article